Clinical guidelines «Obesity in children»
V. A. Peterkova,
O. B. Bezlepkina,
N. V. Bolotova,
E. A. Bogova,
O. V. Vasyukova,
Ya. V. Girsh,
A. V. Kiyaev,
I. B. Kostrova,
O. A. Malievskiy,
E. G. Mikhailova,
P. L. Okorokov,
E. E. Petryaykina,
T. E. Taranushenko,
E. B. Khramova https://doi.org/10.14341/probl12802
Abstract
Childhood obesity is an urgent problem of pediatric endocrinology due to the widespread occurrence, the development of metabolic complications and their steady tracking into adulthood. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of obesity, methods of its diagnosis and treatment based on the principles of evidence-based medicine.
About the Authors
V. A. Peterkova
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Valentina A. Peterkova – MD.
11 Dm. Ulyanova street, 117036, Moscow.
eLibrary SPIN: 4009-2463
Competing Interests:
No conflict of interest.
O. B. Bezlepkina
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Olga B. Bezlepkina – MD.
11 Dm. Ulyanova street, 117036, Moscow.
eLibrary SPIN: 3884-0945
Competing Interests:
No conflict of interest.
N. V. Bolotova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Competing Interests:
Russian Federation
Nina V. Bolotova – MD.
Saratov.
eLibrary SPIN: 5061-1600
Competing Interests:
No conflict of interest.
E. A. Bogova
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Elena A. Bogova – MD.
11 Dm. Ulyanova street, 117036, Moscow.
eLibrary SPIN: 2273-4237
Competing Interests:
No conflict of interest.
O. V. Vasyukova
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Olga V. Vasyukova – MD.
11 Dm. Ulyanova street, 117036, Moscow.
eLibrary SPIN: 6432-3934
Competing Interests:
No conflict of interest.
Ya. V. Girsh
Surgut State University
Russian Federation
Competing Interests:
Russian Federation
Yana V. Girsh – MD.
Surgut.
eLibrary SPIN: 6683-8810
Competing Interests:
No conflict of interest.
A. V. Kiyaev
Ural State Medical University
Russian Federation
Competing Interests:
Russian Federation
Alexey V. Kiyaev -MD, PhD.
Ekaterinburg.
eLibrary SPIN: 7092-7894
Competing Interests:
No conflict of interest.
I. B. Kostrova
N.M. Kuraev Children’s Republican Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Irina B. Kostrova.
Makhachkala.
eLibrary SPIN: 9224-7047
Competing Interests:
No conflict of interest.
O. A. Malievskiy
Bashkir State Medical University
Russian Federation
Competing Interests:
Russian Federation
Oleg A. Malievskiy – MD.
Ufa.
eLibrary SPIN: 6813-5061
Competing Interests:
No conflict of interest.
E. G. Mikhailova
Children’s City Clinical Hospital № 1 named after N.N. Ivanova
Russian Federation
Competing Interests:
Russian Federation
Evgeniia G. Mikhailova – MD.
Samara.
eLibrary SPIN:935-1806
Competing Interests:
No conflict of interest.
P. L. Okorokov
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Pavel L. Okorokov – MD.
11 Dm. Ulyanova street, 117036, Moscow.
eLibrary SPIN: 6989-2620
Competing Interests:
No conflict of interest.
E. E. Petryaykina
Russian Children’s Clinical Hospital, Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Elena E. Petryaykina – MD.
Moscow.
eLibrary SPIN: 5997-7464
Competing Interests:
No conflict of interest.
T. E. Taranushenko
Krasnoyarsk State Medical University named after V.F. Voino-Yasenetsky
Russian Federation
Competing Interests:
Russian Federation
Tatiana E. Taranushenko – MD.
Krasnoyarsk.
elibrary SPIN: 4777-0283
Competing Interests:
No conflict of interest.
E. B. Khramova
Tyumen State Medical University
Russian Federation
Competing Interests:
Russian Federation
Elena B. Khramova - MD, PhD, professor.
Tyumen.
eLibrary SPIN 2462-3440
Competing Interests:
No conflict of interest.
References
1. Federal’nye klinicheskie rekomendatsii (protokoly) po vedeniyu detei s endokrinnymi zabolevaniyami. Ed. by II Dedov, VA Peterkovа. Moscow: Praktika; 2014. 442 p. (In Russ.).
2. Peterkova VA, Vasyukova OV. About the new classification of obesity in the children and adolescents. Problems of Endocrinology. 2015;61(2):39-44. (In Russ.). doi: https://doi.org/10.14341/probl201561239-44
3. Peterkova VA, Vasyukova OV. Redkie formy ozhireniya u detei. Lechashchii vrach. 2008;3:29-33. (In Russ.).
4. World Health Organization. [Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs311/ru/
5. Vasyukova OV. Obesity in children and adolescents: diagnosis criteria. Obesity and metabolism. 2019;16(1):70-73. (In Russ.) doi: https://doi.org/10.14341/omet10170
6. Latest WHO data on child obesity shows that southern European countries have the highest rate of childhood obesity/доклад Dr Joao Breda 25 ЕСО май 2018, Австрия. Available from: WHO/Europe | Nutrition – Latest data shows southern European countries have highest rate of childhood obesity.
7. Peterkova VA, Nagaeva EV, Shiryaeva TYu. Metodicheskie rekomendatsii: Otsenka fizicheskogo razvitiya detei i podrostkov. Moscow; 2017. 98 c. (In Russ.).
8. Aleksandrov AA, Bubnova MG, Kislyak OA, et al. Profilaktika serdechno-sosudistykh zabolevanii v detskom i podrostkovom vozraste. Klinicheskie rekomendatsii. Rossiiskii kardiologicheskii zhurnal. 2012;17(6):1-39. (In Russ.).
9. Agapitov LI, Aleksandrov AA, Baranov AA, et al. Arterial’naya gipertenziya u detei. Klinicheskie rekomendatsii MZ RF. 2016. (In Russ.).
10. Molleston JP, Schwimmer JB, Yates KP, et al. Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels. J Pediatr. 2014;164(4):707-713. doi: https://doi.org/10.1016/j.jpeds.2013.10.071
11. Demura S, Sato S, Kitabayashi T. Percentage of Total Body Fat as Estimated by Three Automatic Bioelectrical Impedance Analyzers. J Physiol Anthropol Appl Human Sci. 2004;23(3):93-99. doi: https://doi.org/10.2114/jpa.23.93
12. Ellis KJ. Measuring body fatness in children and young adults: Comparison of bioelectrical impedance analysis, total body electrical conductivity, and dual-energy x-ray absorptiometry. Int. J. Obes. 1996;20:866-873.
13. Johansson AG, Forslund A, Sjödin A, et al. Determination of body composition—a comparison of dual-energy x-ray absorptiometry and hydrodensitometry. Am J Clin Nutr. 1993;57(3):323-326. doi: https://doi.org/10.1093/ajcn/57.3.323
14. Malavolti M, Mussi C, Poli M, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003;30(4):380-391. doi: https://doi.org/10.1080/0301446031000095211
15. Rekomendatsii po diagnostike, lecheniyu i profilaktike ozhireniya u detei i podrostkov. Moscow: Praktika; 2015. 136 p. (In Russ.).
16. The Academy of Nutrition and Dietetics. Evidence Analysis Library. Pediatric Weight Management Guidelines. 2015. Available from: http://www.adaevidencelibrary.com/topic.cfm?cat=2721
17. Barlow SE. Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report. Pediatrics. 2007;120(S4):S164-S192. doi: https://doi.org/10.1542/peds.2007-2329C
18. Arslanian SA. Clamp Techniques in Paediatrics: What Have We Learned? Horm Res Paediatr. 2005;64(3):16-24. doi: https://doi.org/10.1159/000089313
19. Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin Resistance in Children: Consensus, Perspective, and Future Directions. J Clin Endocrinol Metab. 2010;95(12):5189-5198. doi: https://doi.org/10.1210/jc.2010-1047
20. Yeckel CW, Weiss R, Dziura J, et al. Validation of Insulin Sensitivity Indices from Oral Glucose Tolerance Test Parameters in Obese Children and Adolescents. J Clin Endocrinol Metab. 2004;89(3):1096-1101. doi: https://doi.org/10.1210/jc.2003-031503
21. Styne DM, Arslanian SA, Connor EL, et al. Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(3):709-757. doi: https://doi.org/10.1210/jc.2016-2573
22. Aleksandrov AA, Kislyak OA, Leont’eva IV, Rozanov VB. Diagnostika, lechenie i profilaktika arterial’noi gipertenzii u detei i podrostkov. Rossiiskie rekomendatsii (vtoroi peresmotr). Kardiovaskulyarnaya terapiya i profilaktika. 2009;8(4S1):1-32. (In Russ.).
23. Aleksandrov AA, Bubnova MG, Kislyak OA, et al. Profilaktika serdechno-sosudistykh zabolevanii v detskom i podrostkovom vozraste. Rossiiskie rekomendatsii. Rossiiskii kardiologicheskii zhurnal. 2012;6(98S1):1-40. (In Russ.).
24. WHO. Global’nye rekomendatsii po fizicheskoi aktivnosti dlya zdorov’ya. Moscow: 2010. 60 p. (In Russ.).
25. WHO. WHO guidelines on physical activity, sedentary behavior and sleep for children under 5 years of age. 2019.
26. Kahle E, Zijpf W, Lamb D, et al. Association Between Mild, Routine Exercise and Improved Insulin Dynamics and Glucose Control in Obese Adolescents. Int J Sports Med. 1996;17(01):1-6. doi: https://doi.org/10.1055/s-2007-972799
27. McMurray RG, Bauman MJ, Harrell JS, et al. Effects of improvement in aerobic power on resting insulin and glucose concentrations in children. Eur J Appl Physiol Occup Physiol. 2000;81(1-2):132-139. doi: https://doi.org/10.1007/PL00013786
28. Owens S, Gutin B, Allison J, et al. Effect of physical training on total and visceral fat in obese children. Med Sci Sport Exerc. 1999;31(1):143-148. doi: https://doi.org/10.1097/00005768-199901000-00022
29. Ritenbaugh C, Teufel-Shone NI, Aickin MG, et al. A lifestyle intervention improves plasma insulin levels among Native American high school youth. Prev Med (Baltim). 2003;36(3):309-319. doi: https://doi.org/10.1016/S0091-7435(02)00015-4
30. Chanoine J-P, Hampl S, Jensen C, et al. Effect of Orlistat on Weight and Body Composition in Obese Adolescents. JAMA. 2005;293(23):2873. doi: https://doi.org/10.1001/jama.293.23.2873
31. Mel’nichenko GA, Peterkova VA, Savel’eva LV, Zubkova NA. Evaluation of effectiveness of orlistat in complexed obesity treatment in teenagers with metabolic syndrome. Obesity and metabolism. 2011;8(4):36-42. (In Russ.)]. doi: https://doi.org/10.14341/2071-8713-5302
32. Freemark M. Pharmacotherapy of Childhood Obesity: An evidence-based, conceptual approach. Diabetes Care. 2007;30(2):395-402. doi: https://doi.org/10.2337/dc06-1569
33. Lustig RH, Mietus-Snyder ML, Bacchetti P, et al. Insulin Dynamics Predict Body Mass Index and Z-Score Response to Insulin Suppression or Sensitization Pharmacotherapy in Obese Children. J Pediatr. 2006;148(1):23-29. doi: https://doi.org/10.1016/j.jpeds.2005.08.075
34. Lentferink YE, Knibbe CAJ, van der Vorst MMJ. Efficacy of Metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs. 2018;78(18):1887-1901. doi: https://doi.org/10.1007/s40265-018-1025-0
35. Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism. 2001;50(12):1457-1461. doi: https://doi.org/10.1053/meta.2001.28078
36. Axon E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016;11(11):CD012436. doi: https://doi.org/10.1002/14651858.CD012436
37. Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017;88(6):371-395. doi: https://doi.org/10.1159/000479371
38. Deal CL, Tony M, Höybye C, et al. Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072-E1087. doi: https://doi.org/10.1210/jc.2012-3888
39. Stafler P, Wallis C. Prader-Willi syndrome: who can have growth hormone? Arch Dis Child. 2008;93(4):341-345. doi: https://doi.org/10.1136/adc.2007.126334
40. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117-2128. doi: https://doi.org/10.1056/NEJMoa1916038
41. Mastrandrea LD, Witten L, Carlsson Petri KC, et al. Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes. 2019;14(5):e12495. doi: https://doi.org/10.1111/ijpo.12495
42. Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2003;88(6):2586-2592. doi: https://doi.org/10.1210/jc.2002-030003
43. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999;135(2):162-168. doi: https://doi.org/10.1016/S0022-3476(99)70017-X
44. Lustig RH, Rose SR, Burghen GA, et al. IPEG Guidelines for Surgical Treatment of Extremely Obese Adolescents. J Laparoendosc Adv Surg Tech. 2009;19(1):xiv-xvi. doi: https://doi.org/10.1089/lap.2009.9997
45. Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European Guidelines on Surgery of Severe Obesity. Obes Facts. 2008;1(1):52-59. doi: https://doi.org/10.1159/000113937
46. Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14(7):882-901. doi: https://doi.org/10.1016/j.soard.2018.03.019
47. Black JA, White B, Viner RM, Simmons RK. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14(8):634-644. doi: https://doi.org/10.1111/obr.12037
48. Inge TH, Zeller MH, Jenkins TM, et al. Perioperative Outcomes of Adolescents Undergoing Bariatric Surgery. JAMA Pediatr. 2014;168(1):47. doi: https://doi.org/10.1001/jamapediatrics.2013.4296
49. Göthberg G, Gronowitz E, Flodmark C-E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with morbid obesity—Surgical aspects and clinical outcome. Semin Pediatr Surg. 2014;23(1):11-16. doi: https://doi.org/10.1053/j.sempedsurg.2013.10.015
50. Inge TH, Courcoulas AP, Jenkins TM, et al. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med. 2016;374(2):113-123. doi: https://doi.org/10.1056/NEJMoa1506699
51. Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017;5(3):174-183. doi: https://doi.org/10.1016/S2213-8587(16)30424-7
52. Paulus GF, de Vaan LEG, Verdam FJ, et al. Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-analysis. Obes Surg. 2015;25(5):860-878. doi: https://doi.org/10.1007/s11695-015-1581-2
53. Vasyukova OV. Insulin, leptin, lipidy i perifericheskie rostovye faktory pri ozhirenii u detei. [dissertation] Moscow: 2006. 24 p. (In Russ.).
54. Peterkova VA, Remizov OV. Ozhirenie v detskom vozraste. Obesity and metabolism. 2004;1(1):17-23. (In Russ.). doi: https://doi.org/10.14341/2071-8713-5174
55. Ivashkin VT, Mayevskaya MV, Pavlov ChS, et al. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (In Russ.). doi: https://doi.org/10.22416/1382-4376-2016-26-2-24-42
56. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7-19. doi: https://doi.org/10.1111/pedi.12773
57. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes — 2020. Diabetes Care. 2020;43(S1):S14-S31. doi: https://doi.org/10.2337/dc20-S002
58. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. WHO; IDF: 2006.
59. Comnologiya i meditsina sna. Natsional’noe rukovodstvo pamyati AM Veina i YaI Levina. Ed. by Poluektov MG. Moscow: Medforum; 2016. (In Russ.).
60. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I. Distribution of the Matsuda Index in Japanese healthy subjects. J Diabetes Investig. 2013;4(4):369-371. doi: https://doi.org/10.1111/jdi.12056
61. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017;2017(6). doi: https://doi.org/10.1002/14651858.CD012651
62. Pavlovskaya EV, Surkov AG, Shilina NM, et al. Modern approaches to diet therapy for obesity in children. Vopr Det Dietol. 2016;14(1):41-46. (In Russ.). doi: https://doi.org/10.20953/1727-5784-2016-1-41-46
63. Kedrinskaya AG, Obraztsova GI, Leonova IA. Component composition of the body in children with excessive body mass and obesity. Russ Pediatr J. 2019;21(2):73-77. (In Russ.). doi: https://doi.org/10.18821/1560-9561-2018-21-2-73-77
64. Holm J-C, Gamborg M, Bille DS, et al. Chronic care treatment of obese children and adolescents. Int J Pediatr Obes. 2011;6(3-4):188-196. doi: https://doi.org/10.3109/17477166.2011.575157
65. Ivashkin VT, Maev IV, Baranskaya EK, et al. Rekomendatsii Rossiiskoi gastroenterologicheskoi assotsiatsii po diagnostike i lecheniyu zhelchnokamennoi bolezni. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(3):64-80. (In Russ.). doi: https://doi.org/10.22416/1382-4376-2016-26-3-64-80
66. Passone CDGB, Franco RR, Ito SS, et al. Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open. 2020;4(1):e000630. doi: https://doi.org/10.1136/bmjpo-2019-000630
67. Scheermeyer E, Harris M, Hughes I, et al. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens. Growth Horm IGF Res. 2017;34(1):1-7. doi: https://doi.org/10.1016/j.ghir.2017.03.001
Supplementary files
|
|
1. Figure 1. Algorithm of doctor's actions for the diagnosis and treatment of obesity in children | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(785KB)
|
Indexing metadata ▾ | |
Review
For citations:
Peterkova V.A., Bezlepkina O.B., Bolotova N.V., Bogova E.A., Vasyukova O.V., Girsh Ya.V., Kiyaev A.V., Kostrova I.B., Malievskiy O.A., Mikhailova E.G., Okorokov P.L., Petryaykina E.E., Taranushenko T.E., Khramova E.B. Clinical guidelines «Obesity in children». Problems of Endocrinology. 2021;67(5):67-83. (In Russ.) https://doi.org/10.14341/probl12802
Views:
54190
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
